{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:56:28Z","timestamp":1791186988243,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["DevRes\/Onco\/FIW-2025-01-00000547 (267138)"],"award-info":[{"award-number":["DevRes\/Onco\/FIW-2025-01-00000547 (267138)"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05699-4","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:34:39Z","timestamp":1786955679000},"page":"4771-4796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic targeting of ROCK reverses EMT in lung cancer cells by impeding TAZ in Hippo signalling pathway"],"prefix":"10.1007","volume":"481","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4449-2574","authenticated-orcid":false,"given":"Basab","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5019-0936","authenticated-orcid":false,"given":"Siddhartha Sankar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"5699_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers H (2006) Wnt\/\u03b2-catenin signaling in development and disease. Cell 127:469\u2013480. https:\/\/doi.org\/10.1016\/j.cell.2006.10.018","journal-title":"Cell"},{"key":"5699_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"5699_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.20892\/j.issn.2095-3941.2016.0032","volume":"14","author":"AH Nwabo Kamdje","year":"2017","unstructured":"Nwabo Kamdje AH, Takam Kamga P, Tagne Simo R, Vecchio L, Seke Etet PF, Muller JM et al (2017) Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog. Cancer Biol Med 14:109\u2013120. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0032","journal-title":"Cancer Biol Med"},{"key":"5699_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/138920208783884919","volume":"9","author":"H Ishii","year":"2008","unstructured":"Ishii H, Saito T (2008) Cancer metastasis as disrupted developmental phenotype. Curr Genomics 9:25\u201328. https:\/\/doi.org\/10.2174\/138920208783884919","journal-title":"Curr Genomics"},{"key":"5699_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.20892\/j.issn.2095-3941.2023.0164","volume":"20","author":"T Zhou","year":"2023","unstructured":"Zhou T, Li X, Liu J, Hao J (2023) The Hippo\/YAP signaling pathway: the driver of cancer metastasis. Cancer Biol Med 20:483\u2013489. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0164","journal-title":"Cancer Biol Med"},{"key":"5699_CR6","doi-asserted-by":"publisher","DOI":"10.1242\/dev.167106","author":"JR Davis","year":"2019","unstructured":"Davis JR, Tapon N (2019) Hippo signalling during development. Development. https:\/\/doi.org\/10.1242\/dev.167106","journal-title":"Development"},{"key":"5699_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.371","author":"BJ van Soldt","year":"2020","unstructured":"van Soldt BJ, Cardoso WV (2020) Hippo\u2010Yap\/Taz signaling: complex network interactions and impact in epithelial cell behavior. WIREs Dev Biol. https:\/\/doi.org\/10.1002\/wdev.371","journal-title":"WIREs Dev Biol"},{"key":"5699_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao B, Li L, Tumaneng K, Wang C-Y, Guan K-L (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF \u03b2-TRCP. Genes Dev 24:72\u201385. https:\/\/doi.org\/10.1101\/gad.1843810","journal-title":"Genes Dev"},{"key":"5699_CR9","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.7150\/jca.62402","volume":"12","author":"M Wang","year":"2021","unstructured":"Wang M, Dai M, Wang D, Xiong W, Zeng Z, Guo C (2021) The regulatory networks of the Hippo signaling pathway in cancer development. J Cancer 12:6216\u20136230. https:\/\/doi.org\/10.7150\/jca.62402","journal-title":"J Cancer"},{"key":"5699_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ydbio.2020.12.018","volume":"475","author":"F Szulzewsky","year":"2021","unstructured":"Szulzewsky F, Holland EC, Vasioukhin V (2021) YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Dev Biol 475:205\u2013221. https:\/\/doi.org\/10.1016\/j.ydbio.2020.12.018","journal-title":"Dev Biol"},{"key":"5699_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00389","author":"X Chen","year":"2020","unstructured":"Chen X, Li Y, Luo J, Hou N (2020) Molecular mechanism of Hippo\u2013YAP1\/TAZ pathway in heart development, disease, and regeneration. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2020.00389","journal-title":"Front Physiol"},{"key":"5699_CR12","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-15-0411","volume":"21","author":"A Sebio","year":"2015","unstructured":"Sebio A, Lenz H-J (2015) Molecular pathways: hippo signaling, a critical tumor suppressor. Clin Cancer Res 21:5002\u20135007. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0411","journal-title":"Clin Cancer Res"},{"key":"5699_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112552","author":"MR Kuracha","year":"2024","unstructured":"Kuracha MR, Radhakrishna U, Kuracha SV, Vegi N, Gurung JL, McVicker BL (2024) New horizons in cancer progression and metastasis: hippo signaling pathway. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12112552","journal-title":"Biomedicines"},{"key":"5699_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0244-8","volume":"9","author":"F Deng","year":"2018","unstructured":"Deng F, Peng L, Li Z, Tan G, Liang E, Chen S et al (2018) YAP triggers the Wnt\/\u03b2-catenin signalling pathway and promotes enterocyte self-renewal, regeneration and tumorigenesis after DSS-induced injury. Cell Death Dis 9:153. https:\/\/doi.org\/10.1038\/s41419-017-0244-8","journal-title":"Cell Death Dis"},{"key":"5699_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15206","volume":"8","author":"A Totaro","year":"2017","unstructured":"Totaro A, Castellan M, Battilana G, Zanconato F, Azzolin L, Giulitti S et al (2017) YAP\/TAZ link cell mechanics to Notch signalling to control epidermal stem cell fate. Nat Commun 8:15206. https:\/\/doi.org\/10.1038\/ncomms15206","journal-title":"Nat Commun"},{"key":"5699_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.yexcr.2016.11.024","volume":"350","author":"H-H Ling","year":"2017","unstructured":"Ling H-H, Kuo C-C, Lin B-X, Huang Y-H, Lin C-W (2017) Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer. Exp Cell Res 350:218\u2013225. https:\/\/doi.org\/10.1016\/j.yexcr.2016.11.024","journal-title":"Exp Cell Res"},{"key":"5699_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.molonc.2015.01.007","volume":"9","author":"Z Li","year":"2015","unstructured":"Li Z, Wang Y, Zhu Y, Yuan C, Wang D, Zhang W et al (2015) The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Mol Oncol 9:1091\u20131105. https:\/\/doi.org\/10.1016\/j.molonc.2015.01.007","journal-title":"Mol Oncol"},{"key":"5699_CR18","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/MCB.01874-07","volume":"28","author":"Q-Y Lei","year":"2008","unstructured":"Lei Q-Y, Zhang H, Zhao B, Zha Z-Y, Bai F, Pei X-H et al (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol 28:2426\u20132436. https:\/\/doi.org\/10.1128\/MCB.01874-07","journal-title":"Mol Cell Biol"},{"key":"5699_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5699_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RYJ, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007","journal-title":"Cell"},{"key":"5699_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01957-4","volume":"22","author":"M Liaghat","year":"2024","unstructured":"Liaghat M, Ferdousmakan S, Mortazavi SH, Yahyazadeh S, Irani A, Banihashemi S et al (2024) The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors. Cell Commun Signal 22:575. https:\/\/doi.org\/10.1186\/s12964-024-01957-4","journal-title":"Cell Commun Signal"},{"key":"5699_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA (2017) EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol 14:611\u2013629. https:\/\/doi.org\/10.1038\/nrclinonc.2017.44","journal-title":"Nat Rev Clin Oncol"},{"key":"5699_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cell.2014.06.004","volume":"158","author":"DD Shao","year":"2014","unstructured":"Shao DD, Xue W, Krall EB, Bhutkar A, Piccioni F, Wang X et al (2014) KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 158:171\u2013184. https:\/\/doi.org\/10.1016\/j.cell.2014.06.004","journal-title":"Cell"},{"key":"5699_CR24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"F-X Yu","year":"2012","unstructured":"Yu F-X, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH et al (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150:780\u2013791. https:\/\/doi.org\/10.1016\/j.cell.2012.06.037","journal-title":"Cell"},{"key":"5699_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.devcel.2013.01.020","volume":"24","author":"BVVG Reddy","year":"2013","unstructured":"Reddy BVVG, Irvine KD (2013) Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev Cell 24:459\u2013471. https:\/\/doi.org\/10.1016\/j.devcel.2013.01.020","journal-title":"Dev Cell"},{"key":"5699_CR26","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00018-016-2412-x","volume":"74","author":"MH Kim","year":"2017","unstructured":"Kim MH, Kim J (2017) Role of YAP\/TAZ transcriptional regulators in resistance to anti-cancer therapies. Cell Mol Life Sci 74:1457\u20131474. https:\/\/doi.org\/10.1007\/s00018-016-2412-x","journal-title":"Cell Mol Life Sci"},{"key":"5699_CR27","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cell.2012.11.026","volume":"151","author":"J Rosenbluh","year":"2012","unstructured":"Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ et al (2012) \u03b2-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151:1457\u20131473. https:\/\/doi.org\/10.1016\/j.cell.2012.11.026","journal-title":"Cell"},{"key":"5699_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/19336918.2017.1338233","author":"W Sugimoto","year":"2017","unstructured":"Sugimoto W, Itoh K, Mitsui Y, Ebata T, Fujita H, Hirata H et al (2017) Substrate rigidity-dependent positive feedback regulation between YAP and ROCK2. Cell Adh Migr. https:\/\/doi.org\/10.1080\/19336918.2017.1338233","journal-title":"Cell Adh Migr"},{"key":"5699_CR29","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1038\/s41467-019-10729-5","volume":"10","author":"J Park","year":"2019","unstructured":"Park J, Kim D-H, Shah SR, Kim H-N, Kshitiz, Kim P et al (2019) Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases. Nat Commun 10:2797. https:\/\/doi.org\/10.1038\/s41467-019-10729-5","journal-title":"Nat Commun"},{"key":"5699_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/FJC.0b013e318070d1bd","volume":"50","author":"JK Liao","year":"2007","unstructured":"Liao JK, Seto M, Noma K (2007) Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 50:17\u201324. https:\/\/doi.org\/10.1097\/FJC.0b013e318070d1bd","journal-title":"J Cardiovasc Pharmacol"},{"key":"5699_CR31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12203","author":"S K\u00fcmper","year":"2016","unstructured":"K\u00fcmper S, Mardakheh FK, McCarthy A, Yeo M, Stamp GW, Paul A et al (2016) Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis. Elife. https:\/\/doi.org\/10.7554\/eLife.12203","journal-title":"Elife"},{"key":"5699_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tcb.2019.10.005","volume":"30","author":"V Rausch","year":"2020","unstructured":"Rausch V, Hansen CG (2020) The Hippo pathway, YAP\/TAZ, and the plasma membrane. Trends Cell Biol 30:32\u201348. https:\/\/doi.org\/10.1016\/j.tcb.2019.10.005","journal-title":"Trends Cell Biol"},{"key":"5699_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-025-00760-4","volume":"30","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, He P, Yang L, Gong J, Qin R, Wang M (2025) Posttranslational modifications of YAP\/TAZ: molecular mechanisms and therapeutic opportunities. Cell Mol Biol Lett 30:83. https:\/\/doi.org\/10.1186\/s11658-025-00760-4","journal-title":"Cell Mol Biol Lett"},{"key":"5699_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133468","volume":"15","author":"RB Mokhtari","year":"2023","unstructured":"Mokhtari RB, Ashayeri N, Baghaie L, Sambi M, Satari K, Baluch N et al (2023) The Hippo pathway effectors YAP\/TAZ-TEAD oncoproteins as emerging therapeutic targets in the tumor microenvironment. Cancers 15:3468. https:\/\/doi.org\/10.3390\/cancers15133468","journal-title":"Cancers"},{"key":"5699_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan K-L, Luo T, Luo M (2022) The hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther 7:376. https:\/\/doi.org\/10.1038\/s41392-022-01191-9","journal-title":"Signal Transduct Target Ther"},{"key":"5699_CR36","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13279","volume":"23","author":"A Farooqi","year":"2022","unstructured":"Farooqi A, Zahid R, Naureen H, Attar R, Gazouli M, Berardi R et al (2022) Regulation of ROCK1\/2 by long non-coding RNAs and circular RNAs in different cancer types (Review). Oncol Lett 23:159. https:\/\/doi.org\/10.3892\/ol.2022.13279","journal-title":"Oncol Lett"},{"key":"5699_CR37","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4864","author":"C Hu","year":"2019","unstructured":"Hu C, Zhou H, Liu Y, Huang J, Liu W, Zhang Q et al (2019) ROCK1 promotes migration and invasion of non-small-cell lung cancer cells through the PTEN\/PI3K\/FAK pathway. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2019.4864","journal-title":"Int J Oncol"},{"key":"5699_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00713-2","volume":"19","author":"SE Leggett","year":"2021","unstructured":"Leggett SE, Hruska AM, Guo M, Wong IY (2021) The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems. Cell Commun Signal 19:32. https:\/\/doi.org\/10.1186\/s12964-021-00713-2","journal-title":"Cell Commun Signal"},{"key":"5699_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume-title":"Small-Molecule Library Screening by Docking with PyRx","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-Molecule Library Screening by Docking with PyRx. Springer, Cham, pp 243\u2013250. https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19"},{"key":"5699_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/minf.202100300","author":"T Kandasamy","year":"2022","unstructured":"Kandasamy T, Sen P, Ghosh SS (2022) Multi\u2010targeted drug repurposing approach for breast cancer via integrated functional network analysis. Mol Inform. https:\/\/doi.org\/10.1002\/minf.202100300","journal-title":"Mol Inform"},{"key":"5699_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00441-014-1953-2","volume":"358","author":"Z Liu","year":"2014","unstructured":"Liu Z, Chen X, Song H, Wang H, Zhang G, Wang H et al (2014) Snail regulated by PKC\/GSK-3\u03b2 pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells. Cell Tissue Res 358:491\u2013502. https:\/\/doi.org\/10.1007\/s00441-014-1953-2","journal-title":"Cell Tissue Res"},{"key":"5699_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1165\/rcmb.2007-0071OC","volume":"38","author":"Y Shintani","year":"2008","unstructured":"Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ (2008) Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor\u2013\u03b2 signaling. Am J Respir Cell Mol Biol 38:95\u2013104. https:\/\/doi.org\/10.1165\/rcmb.2007-0071OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"5699_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1535-6108(03)00304-0","volume":"4","author":"Z Lu","year":"2003","unstructured":"Lu Z, Ghosh S, Wang Z, Hunter T (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of \u03b2-catenin, and enhanced tumor cell invasion. Cancer Cell 4:499\u2013515. https:\/\/doi.org\/10.1016\/S1535-6108(03)00304-0","journal-title":"Cancer Cell"},{"key":"5699_CR44","doi-asserted-by":"publisher","first-page":"74006","DOI":"10.18632\/oncotarget.18598","volume":"8","author":"N Saito","year":"2017","unstructured":"Saito N, Mine N, Kufe DW, Von Hoff DD, Kawabe T (2017) CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding. Oncotarget 8:74006\u201374018. https:\/\/doi.org\/10.18632\/oncotarget.18598","journal-title":"Oncotarget"},{"key":"5699_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-273","volume":"12","author":"W-L Chen","year":"2012","unstructured":"Chen W-L, Kuo K-T, Chou T-Y, Chen C-L, Wang C-H, Wei Y-H et al (2012) The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis. BMC Cancer 12:273. https:\/\/doi.org\/10.1186\/1471-2407-12-273","journal-title":"BMC Cancer"},{"key":"5699_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155551","volume":"262","author":"I Akrida","year":"2024","unstructured":"Akrida I, Makrygianni M, Nikou S, Mulita F, Bravou V, Papadaki H (2024) Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors. Pathol Res Pract 262:155551. https:\/\/doi.org\/10.1016\/j.prp.2024.155551","journal-title":"Pathol Res Pract"},{"key":"5699_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14348\/molcells.2018.2242","volume":"41","author":"JH Park","year":"2018","unstructured":"Park JH, Shin JE, Park HW (2018) The role of hippo pathway in cancer stem cell biology. Mol Cells 41:83\u201392. https:\/\/doi.org\/10.14348\/molcells.2018.2242","journal-title":"Mol Cells"},{"key":"5699_CR48","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1002\/cam4.2174","volume":"8","author":"Y Chang","year":"2019","unstructured":"Chang Y, Fu X-R, Cui M, Li W-M, Zhang L, Li X et al (2019) Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK\/T cell lymphoma cells. Cancer Med 8:3892\u20133904. https:\/\/doi.org\/10.1002\/cam4.2174","journal-title":"Cancer Med"},{"key":"5699_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03946-0","volume":"25","author":"Y Feng","year":"2025","unstructured":"Feng Y, Gan X, Rong X, Han Q (2025) The components and regulation of the Hippo pathway and its relationships with the progression and treatment of non-small cell lung cancer (NSCLC). Cancer Cell Int 25:309. https:\/\/doi.org\/10.1186\/s12935-025-03946-0","journal-title":"Cancer Cell Int"},{"key":"5699_CR50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ccell.2018.08.009","volume":"34","author":"S Kitajima","year":"2018","unstructured":"Kitajima S, Asahina H, Chen T, Guo S, Quiceno LG, Cavanaugh JD et al (2018) Overcoming resistance to dual innate immune and MEK inhibition downstream of KRAS. Cancer Cell 34:439-452.e6. https:\/\/doi.org\/10.1016\/j.ccell.2018.08.009","journal-title":"Cancer Cell"},{"key":"5699_CR51","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1158\/0008-5472.CAN-14-3396","volume":"75","author":"W Zhang","year":"2015","unstructured":"Zhang W, Gao Y, Li F, Tong X, Ren Y, Han X et al (2015) YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin. Cancer Res 75:4450\u20134457. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3396","journal-title":"Cancer Res"},{"key":"5699_CR52","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/JTO.0b013e318248240b","volume":"7","author":"M Xie","year":"2012","unstructured":"Xie M, Zhang L, He C-S, Hou J-H, Lin S-X, Hu Z-H et al (2012) Prognostic significance of TAZ expression in resected non-small cell lung cancer. J Thorac Oncol 7:799\u2013807. https:\/\/doi.org\/10.1097\/JTO.0b013e318248240b","journal-title":"J Thorac Oncol"},{"key":"5699_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0613-5","volume":"11","author":"L Zheng","year":"2018","unstructured":"Zheng L, Xiang C, Li X, Guo Q, Gao L, Ni H et al (2018) STARD13-correlated ceRNA network-directed inhibition on YAP\/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase\/F-actin signaling. J Hematol Oncol 11:72. https:\/\/doi.org\/10.1186\/s13045-018-0613-5","journal-title":"J Hematol Oncol"},{"key":"5699_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1506-3","volume":"38","author":"C Zucchini","year":"2019","unstructured":"Zucchini C, Manara MC, Cristalli C, Carrabotta M, Greco S, Pinca RS et al (2019) ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity. J Exp Clin Cancer Res 38:503. https:\/\/doi.org\/10.1186\/s13046-019-1506-3","journal-title":"J Exp Clin Cancer Res"},{"key":"5699_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110529","volume":"102","author":"P Sen","year":"2023","unstructured":"Sen P, Kandasamy T, Ghosh SS (2023) Multi-targeting TACE\/ADAM17 and gamma-secretase of notch signalling pathway in TNBC via drug repurposing approach using Lomitapide. Cell Signal 102:110529. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110529","journal-title":"Cell Signal"},{"key":"5699_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05039-6","volume":"13","author":"B Lee","year":"2022","unstructured":"Lee B, Park SJ, Lee S, Lee J, Lee E, Yoo E-S et al (2022) Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR. Cell Death Dis 13:603. https:\/\/doi.org\/10.1038\/s41419-022-05039-6","journal-title":"Cell Death Dis"},{"key":"5699_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41420-023-01359-4","volume":"9","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang S, He H, Luo H, Xia Y, Jiang Y et al (2023) Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in preclinical pancreatic cancer models. Cell Death Discov 9:60. https:\/\/doi.org\/10.1038\/s41420-023-01359-4","journal-title":"Cell Death Discov"},{"key":"5699_CR58","doi-asserted-by":"publisher","first-page":"10065","DOI":"10.1007\/s11033-022-07590-z","volume":"49","author":"I Akrida","year":"2022","unstructured":"Akrida I, Bravou V, Papadaki H (2022) The deadly cross-talk between Hippo pathway and epithelial\u2013mesenchymal transition (EMT) in cancer. Mol Biol Rep 49:10065\u201310076. https:\/\/doi.org\/10.1007\/s11033-022-07590-z","journal-title":"Mol Biol Rep"},{"key":"5699_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-10-94","volume":"10","author":"S Das","year":"2009","unstructured":"Das S, Becker BN, Hoffmann FM, Mertz JE (2009) Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway. BMC Cell Biol 10:94. https:\/\/doi.org\/10.1186\/1471-2121-10-94","journal-title":"BMC Cell Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05699-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05699-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05699-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:45:28Z","timestamp":1791186328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05699-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5699"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05699-4","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"6 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}